Once in limbo, promising new muscular dystrophy drug back on track toward approval

A new drug designed to slow the progression of Duchenne muscular dystrophy , a devastating disease that overwhelmingly affects boys and typically leaves them needing wheelchairs by their teens and dead in their 20s, has received a long-awaited boost from the Food and Drug Administration.

http://ift.tt/1r7YMPO